Hypervigilance, Allostatic Load, and Migraine Prevention: Antibodies to CGRP or Receptor

por Blumenfeld, Andrew, Durham, Paul L., Feoktistov, Alexander, Hay, Debbie L., Russo, Andrew F., Turner, Ira
Publicado 2021

Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials

por Stauffer, Virginia L., Turner, Ira, Kemmer, Phebe, Kielbasa, William, Day, Kathleen, Port, Martha, Quinlan, Tonya, Camporeale, Angelo
Publicado 2020

Patient-Reported Outcomes from a 1-Year, Real-World, Head-to-Head Comparison of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine

por Blumenfeld, Andrew M., Patel, Atul T., Turner, Ira M., Mullin, Kathleen B., Manack Adams, Aubrey, Rothrock, John F.
Publicado 2020

Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: findings from the phase 3 trials (SAMURAI and SPARTAN)

por Loo, Li Shen, Plato, Brian M., Turner, Ira M., Case, Michael G., Raskin, Joel, Dowsett, Sherie A., Krege, John H.
Publicado 2019